Casdin Partners Master Fund, L.P.
CIK 1534265 · last filed 2025-12-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLFS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
87 MARY STREET
GEORGE TOWN
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LAB | Director | 75,001,062 | $0.61 | $45.69M | $1.88M | 2 | 2025-12-04 |
| BIOLIFE SOLUTIONS INC (BLFS) Delisted | 10%+ Owner | 14,664,330 | $38.61 | $566.19M | -$21.41M | 2 | 2025-10-17 |
| 2seventy bio, Inc. (TSVT) Delisted | Director | 2,016,600 | $5.00 | $10.08M | $204.0K | 1 | 2024-03-28 |
| Verve Therapeutics, Inc. (VERV) Delisted | 10%+ Owner | 2,417,596 | $11.13 | $26.91M | $20.90M | 1 | 2021-06-22 |
| Decibel Therapeutics, Inc. (DBTX) Delisted | 10%+ Owner | 1,121,421 | $4.91 | $5.51M | $10.35M | 1 | 2021-02-19 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| LAB | Direct | 2,901,062 | 3.9% | 2025-12-04 |
| Casdin Private Growth Equity Fund, L.P. See footnote |
72,100,000 | 96.1% | 2025-12-04 | |
| Total | 75,001,062 | |||
| BLFS | Direct | 8,707,165 | 59.4% | 2024-05-02 |
| Footonote | 5,957,165 | 40.6% | 2025-10-17 | |
| Total | 14,664,330 | |||
| No longer reported | ||||
| See footnote | 0 | — | last 2024-05-02 | |
| TSVT | Direct | 16,600 | 0.8% | 2024-03-28 |
| Casdin Partners Master Fund, L.P. See footnote. |
2,000,000 | 99.2% | 2024-03-28 | |
| Total | 2,016,600 | |||
| DBTX | Casdin Partners Master Fund, L.P. See footnote |
1,121,421 | 100.0% | 2021-02-19 |
| Total | 1,121,421 | |||
Recent Filings · Page 2 of 2
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-10 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Notice (144) 10% Owner · Planned Jun 10, 2025 Sold: listed on the Aug 11, 2025 notice |
−1,000,000 | -$23.91M | EDGAR |
| 2024-05-02 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Other (J) | — | $0 | EDGAR |
| 2024-03-28 | 2seventy bio, Inc. (TSVT) Delisted | Buy (P) | +40,000 | $204.0K | EDGAR |
| 2021-06-22 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | +2,417,596 | $20.90M | EDGAR |
| 2021-02-19 | Decibel Therapeutics, Inc. (DBTX) Delisted | Mixed | +1,121,421 | $10.35M | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
5 sales · $60.02M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2026-05-20 | BLFS | 250,000 | $5.92M | $23.70 | 2026-05-21 |
| 2026-05-19 | BLFS | 300,000 | $6.79M | $22.65 | 2026-05-20 |
| 2025-08-15 | BLFS | 500,000 | $12.20M | $24.40 | 2025-10-15 |
| 2025-08-11 | BLFS | 500,000 | $11.30M | $22.60 | 2025-08-15 |
| 2025-06-10 | BLFS | 1,000,000 | $23.80M | $23.80 | 2025-08-11 |